Johnson & Johnson (JNJ)

Return on total capital

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 32,169,000 28,189,000 27,408,000 17,442,000 18,395,000 20,273,000 20,778,000 15,834,000 15,235,000 16,124,000 15,479,000 22,426,000 22,944,000 20,515,000 21,339,000 22,959,000 19,797,000 20,373,000 17,656,000 16,698,000
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 79,277,000 78,473,000 78,109,000 71,490,000 70,158,000 71,538,000 70,020,000 68,774,000 71,228,000 75,149,000 70,869,000 76,804,000 74,599,000 76,357,000 74,709,000 74,023,000 70,272,000 69,580,000 65,834,000 63,278,000
Return on total capital 40.58% 35.92% 35.09% 24.40% 26.22% 28.34% 29.67% 23.02% 21.39% 21.46% 21.84% 29.20% 30.76% 26.87% 28.56% 31.02% 28.17% 29.28% 26.82% 26.39%

September 30, 2025 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $32,169,000K ÷ ($—K + $79,277,000K)
= 40.58%